GlassScriptPhysician profile
Michelle Morgan
NPI 1992426555
$705.12
in general payments reported to CMS, 2019-2025
11 companies · $36.97 in 2025
The $36.97 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $475 · 2024: $193 · 2025: $36.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $132.97 | 2023-2025 | Caplyta |
| Alkermes, INC. | $114.34 | 2023-2024 | Lybalvi, Aristada |
| Neurocrine Biosciences, INC. | $103.50 | 2023-2024 | Ingrezza |
| Abbvie INC. | $78.89 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.43 | 2023-2025 | Trintellix |
| Lundbeck LLC | $46.59 | 2023-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $42.23 | 2023 | Abilify Mycite |
| Axsome Therapeutics, INC. | $38.01 | 2023 | Auvelity |
| Idorsia Pharmaceuticals US INC | $37.34 | 2023 | Quviviq |
| Supernus Pharmaceuticals, INC. | $33.88 | 2023 | Qelbree |
| Janssen Pharmaceuticals, INC | $29.94 | 2024 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.